BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17673474)

  • 1. Development of solitary plasmacytoma in the internal auditory canal and inner ear after allogeneic hematopoietic stem cell transplantation for plasma cell leukemia.
    Masuda M; Inoue Y; Tanosaki R; Kanzaki S; Ogawa K
    Jpn J Clin Oncol; 2007 Sep; 37(9):701-3. PubMed ID: 17673474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of primary plasma cell leukaemia by allogeneic stem cell transplantation from haploidentical sibling.
    Nonami A; Miyamoto T; Kuroiwa M; Kunisaki Y; Kamezaki K; Takenaka K; Harada N; Teshima T; Harada M; Nagafuji K
    Jpn J Clin Oncol; 2007 Dec; 37(12):969-72. PubMed ID: 18055567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary metastasis of lung carcinoma to the internal auditory canal.
    Schrock A; Laffers W; Bootz F
    Am J Otolaryngol; 2006; 27(3):214-6. PubMed ID: 16647989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cavernous angioma of the internal auditory canal.
    Aquilina K; Nanra JS; Brett F; Walsh RM; Rawluk D
    J Laryngol Otol; 2004 May; 118(5):368-71. PubMed ID: 15165313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningioma of the internal auditory canal: a case report.
    Khaimook W; Hirunpat S; Dejsukum C
    J Med Assoc Thai; 2005 Nov; 88(11):1707-11. PubMed ID: 16471123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary disease caused by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation--a case report and literature review].
    Chen B; Wu DP; Sun AN; Qiu HY; Fu ZZ; Tang XW; Ma X; Jin ZM; Miao M; He GS; Liu YJ; Zhao Y; Wu XJ; Zhu XM
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):470-2. PubMed ID: 15555262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple myeloma relapsed or progressed as plasmacytoma after allogeneic reduced-intensity stem cell transplantation: report of three cases].
    Sugimoto Y; Nishii K; Miyata E; Fujieda A; Yamaguchi M; Masuya M; Katayama N
    Rinsho Ketsueki; 2009 Apr; 50(4):289-94. PubMed ID: 19404022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose chemotherapy and allogenic peripheral blood stem cell transplantation for multiple myeloma evolving from intra-abdominal plasmacytoma.
    Chung KM; Chuang SS; Hwang WS; Lee PS; Li CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Nov; 65(11):557-60. PubMed ID: 12583522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic advances in the treatment of primary plasma cell leukemia: a focus on hematopoietic cell transplantation.
    Nishihori T; Abu Kar SM; Baz R; Alsina M; Harousseau JL; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1144-51. PubMed ID: 23416092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued disease activity in a patient with multiple sclerosis after allogeneic hematopoietic cell transplantation.
    Lu JQ; Storek J; Metz L; Yong VW; Stevens AM; Nash RA; Joseph JT
    Arch Neurol; 2009 Jan; 66(1):116-20. PubMed ID: 19139309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male breast cancer 15 years after allogeneic hematopoietic cell transplantation including total body irradiation for recurrent acute lymphoblastic leukemia.
    Lowe T; Luu T; Shen J; Bhatia S; Shibata S; Stein A; Somlo G
    Onkologie; 2008 May; 31(5):266-9. PubMed ID: 18497517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCT.
    Konuma T; Ooi J; Takahashi S; Tomonari A; Tsukada N; Kato S; Sato A; Monma F; Kasahara S; Uchimaru K; Iseki T; Tojo A; Asano S
    Leuk Res; 2009 Jun; 33(6):840-2. PubMed ID: 18995897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extramedullary relapse following allogeneic stem cell transplantation in acute promyelocytic leukemia: the role of ATRA.
    Ustün C; Arat M; Celebi H; Akan H; Ilhan O; Ozçelik T; Burgess RE; Koc H
    Haematologica; 2001 Oct; 86(10):E31. PubMed ID: 11602438
    [No Abstract]   [Full Text] [Related]  

  • 17. Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation.
    Yoshimi A; Izutsu K; Takahashi M; Kako S; Oshima K; Kanda Y; Motokura T; Chiba S; Momose T; Ohtomo K; Kurokawa M
    Am J Hematol; 2008 Jun; 83(6):477-81. PubMed ID: 18266206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized extramedullary relapse after autologous hematopoietic stem cell transplantation in multiple myeloma.
    Erkus M; Bolaman Z; Meteoglu I; Kadikoylu G
    Saudi Med J; 2005 Jun; 26(6):989-91. PubMed ID: 15983690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic stem cell transplantation for chronic myeloid leukemia-status in 2007.
    Goldman J
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S11-S13. PubMed ID: 18724281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prediction of T-cell immune reconstitution by investigating T cell receptor excision circle and T-cell receptor beta-chain variable region clonal repertoire in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW; Wu DP; Cen JN; Feng YF; Chang WR; Qiu QC; Zhu ZL; Zhu P
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2265-7. PubMed ID: 18001548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.